OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AA2. A total of 20 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $977,000 | – | 1,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 3,000,000 | $2,946,000 | 0.52% |
| PFM Health Sciences, LP | 12,635,000 | $12,406,000 | 0.25% |
| WHITEBOX ADVISORS LLC | 5,500,000 | $5,373,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,500,000 | $2,429,000 | 0.22% |
| Myriad Asset Management Ltd. | 500,000 | $487,000 | 0.13% |
| Jabre Capital Partners S.A. | 1,500,000 | $1,474,000 | 0.11% |
| Orbimed Advisors | 7,500,000 | $7,317,000 | 0.11% |
| STEELHEAD PARTNERS LLC | 1,000,000 | $980,000 | 0.09% |
| Perceptive Advisors | 750,000 | $732,000 | 0.09% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,500,000 | $5,377,000 | 0.07% |